Ardent Health (ARDT) Investor Alert: Hagens Berman Investigating Accounting Estimate Change and $97M Reserve Issue Driving 33% Plunge
ARDT INVESTIGATION: Robbins Geller Rudman & Dowd LLP Launches Investigation into Ardent Health, Inc., and Encourages Investors and Potential Witnesses to Contact Law Firm
ARDT INVESTIGATION ALERT: Edelson Lechtzin LLP Announces an Investigation of Ardent Health, Inc. (NYSE: ARDT) and Encourages Investors with Substantial Losses to Contact the Firm
Ardent Health (NYSE:ARDT) was given a new $14.00 price target on by analysts at UBS Group AG.
Ardent Health (NYSE:ARDT) had its price target lowered by analysts at Mizuho from $20.00 to $12.00. They now have an "outperform" rating on the stock.